The combined neuroprotective, synaptogenic, and neurogenic mechanisms activated by these compounds encourage the possibility that they may offer a treatment option for neurodegenerative and neuro-traumatic disorders beyond AD
As an antimicrobial and biomaterial adjunct, it might potentially contribute to composite research design
Because scientific research often evolves through the investigation of newly introduced compounds, SLU-PP-332 may be incorporated into structured laboratory programs designed to support documentation, repeatability, and organized analytical review
Naturally present in the human body
Baseline levels of GHK-Cu in the human body peak at roughly 200 ng/mL during late adolescence (around age 20), but suffer a precipitous and permanent decline as an individual ages, dropping to approximately 80 ng/mL by age 60